Cargando…
Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
BACKGROUND: Omentin and adiponectin are among the anti-inflammatory and anti-atherogenic adipokines that have potentially beneficial effects on cardiovascular disorders. Recent studies indicate a paradoxical relationship between adiponectin and cardiovascular mortality across many clinical settings...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894467/ https://www.ncbi.nlm.nih.gov/pubmed/31805941 http://dx.doi.org/10.1186/s12933-019-0973-3 |
_version_ | 1783476392910913536 |
---|---|
author | Nishimura, Masami Morioka, Tomoaki Hayashi, Mariko Kakutani, Yoshinori Yamazaki, Yuko Kurajoh, Masafumi Mori, Katsuhito Fukumoto, Shinya Shioi, Atsushi Shoji, Tetsuo Inaba, Masaaki Emoto, Masanori |
author_facet | Nishimura, Masami Morioka, Tomoaki Hayashi, Mariko Kakutani, Yoshinori Yamazaki, Yuko Kurajoh, Masafumi Mori, Katsuhito Fukumoto, Shinya Shioi, Atsushi Shoji, Tetsuo Inaba, Masaaki Emoto, Masanori |
author_sort | Nishimura, Masami |
collection | PubMed |
description | BACKGROUND: Omentin and adiponectin are among the anti-inflammatory and anti-atherogenic adipokines that have potentially beneficial effects on cardiovascular disorders. Recent studies indicate a paradoxical relationship between adiponectin and cardiovascular mortality across many clinical settings including type 2 diabetes. In this study, we characterized the clinical features of type 2 diabetes patients with increased adiponectin levels and examined the association between omentin and atherosclerosis in those patients. METHODS: The subjects were 413 patients with type 2 diabetes. Fasting plasma omentin and total adiponectin levels were measured by enzyme-linked immunosorbent assay. The intima-media thickness (IMT) of the common carotid artery was measured by ultrasonography. The subjects were stratified according to the median value of plasma adiponectin. RESULTS: In high-adiponectin group, omentin levels were higher, while IMT tended to be greater than those in low-adiponectin group. The high-adiponectin group also exhibited older age, higher systolic blood pressure, lower kidney function, body mass index, and insulin resistance index compared to the low-adiponectin group. Multivariate analysis revealed that omentin levels were independently and negatively associated with IMT in high-adiponectin group, but not in low-adiponectin group, after adjusting for adiponectin levels and traditional cardiovascular risk factors. On the other hand, adiponectin levels were not significantly associated with IMT in either group. CONCLUSIONS: Plasma omentin levels are inversely associated with IMT in type 2 diabetes patients with increased adiponectin levels and multiple cardiovascular risk factors. This study suggests a protective role of omentin against atherosclerosis in type 2 diabetes patients, which is potentially influenced by adiponectin level and cardiovascular risk status. |
format | Online Article Text |
id | pubmed-6894467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68944672019-12-11 Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study Nishimura, Masami Morioka, Tomoaki Hayashi, Mariko Kakutani, Yoshinori Yamazaki, Yuko Kurajoh, Masafumi Mori, Katsuhito Fukumoto, Shinya Shioi, Atsushi Shoji, Tetsuo Inaba, Masaaki Emoto, Masanori Cardiovasc Diabetol Original Investigation BACKGROUND: Omentin and adiponectin are among the anti-inflammatory and anti-atherogenic adipokines that have potentially beneficial effects on cardiovascular disorders. Recent studies indicate a paradoxical relationship between adiponectin and cardiovascular mortality across many clinical settings including type 2 diabetes. In this study, we characterized the clinical features of type 2 diabetes patients with increased adiponectin levels and examined the association between omentin and atherosclerosis in those patients. METHODS: The subjects were 413 patients with type 2 diabetes. Fasting plasma omentin and total adiponectin levels were measured by enzyme-linked immunosorbent assay. The intima-media thickness (IMT) of the common carotid artery was measured by ultrasonography. The subjects were stratified according to the median value of plasma adiponectin. RESULTS: In high-adiponectin group, omentin levels were higher, while IMT tended to be greater than those in low-adiponectin group. The high-adiponectin group also exhibited older age, higher systolic blood pressure, lower kidney function, body mass index, and insulin resistance index compared to the low-adiponectin group. Multivariate analysis revealed that omentin levels were independently and negatively associated with IMT in high-adiponectin group, but not in low-adiponectin group, after adjusting for adiponectin levels and traditional cardiovascular risk factors. On the other hand, adiponectin levels were not significantly associated with IMT in either group. CONCLUSIONS: Plasma omentin levels are inversely associated with IMT in type 2 diabetes patients with increased adiponectin levels and multiple cardiovascular risk factors. This study suggests a protective role of omentin against atherosclerosis in type 2 diabetes patients, which is potentially influenced by adiponectin level and cardiovascular risk status. BioMed Central 2019-12-05 /pmc/articles/PMC6894467/ /pubmed/31805941 http://dx.doi.org/10.1186/s12933-019-0973-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Nishimura, Masami Morioka, Tomoaki Hayashi, Mariko Kakutani, Yoshinori Yamazaki, Yuko Kurajoh, Masafumi Mori, Katsuhito Fukumoto, Shinya Shioi, Atsushi Shoji, Tetsuo Inaba, Masaaki Emoto, Masanori Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study |
title | Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study |
title_full | Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study |
title_fullStr | Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study |
title_full_unstemmed | Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study |
title_short | Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study |
title_sort | plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894467/ https://www.ncbi.nlm.nih.gov/pubmed/31805941 http://dx.doi.org/10.1186/s12933-019-0973-3 |
work_keys_str_mv | AT nishimuramasami plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT moriokatomoaki plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT hayashimariko plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT kakutaniyoshinori plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT yamazakiyuko plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT kurajohmasafumi plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT morikatsuhito plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT fukumotoshinya plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT shioiatsushi plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT shojitetsuo plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT inabamasaaki plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy AT emotomasanori plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy |